NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis

British Journal of Pharmacology

Volumn 130, Issue 6, 2000, Pages 1399-1405

  Cicala, Carla ^a   Ianaro, Angela ^a   Fiorucci, Stefano ^b   Calignano, Antonio ^a   Bucci, Mariarosaria ^a   Gerli, Roberto ^b   Santucci, Luca ^b   Wallace, John L ^c   Cirino, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Draining lymph nodes; Freund's adjuvant arthritis; IL 2; Naproxen; Pain; Proliferation; Rat

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIPYRETIC AGENT; CONCANAVALIN A; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; NAPROXEN; NITROGEN OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA SYNTHESIS; DOWN REGULATION; LYMPHOCYTE PROLIFERATION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; FLOW CYTOMETRY; HINDLIMB; INFLAMMATION; INTERLEUKIN-1; MALE; NAPROXEN; NITRIC OXIDE; NOCICEPTORS; PAIN; PAIN MEASUREMENT; RATS; RATS, INBRED LEW; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; THYMIDINE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033930488     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703449     Document Type: Article

References (28)

1. BARNES, P.J. & LIEW, F.Y. (1994). Nitric oxide and asthmatic inflammation. Immunol. Today, 16, 128-130.
2. 1 phase of the cell cycle. Biochem. Pharmacol., 28, 441-443.
3. CHARLES, I.G., PALMER, R.J., HICKERY, M.S., BAYLISS, M.T., CHUBB, A.P., HALL, V.S., MOSS, D.W. & MONCADA, S. (1993). Cloning, characterization and expression of a cDNA encoding an inducible nitric oxide synthase from human chondrocytes. Proc. Natl. Acad. Sci. U.S.A., 90, 11419-11423.
4. CIRINO, G., WHEELER-JONES, C.P.D., WALLACE, J.L., DEE SOLDATO, P. & BAYDOUN, A.R. (1996). Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing properties. Br. J. Pharmacol., 117, 1421-1426.
5. DAVIES, N.M., ROSETH, A.G., APPLEYARD, C B., MCKNIGHT, W., DEL SOLDATO, P., CALIGNANO, A., CIRINO, G. & WALLACE, J.L. (1997). NO-naproxen vs naproxen: ulcerogenic, analgesic and anti-inflammatory effects. Aliment. Pharm. Ther., 11, 69-79.
6. FELDMANN, M., BRENNAN, F.M. & MAINI, R.N. (1996). Role of cytokines in rheumatoid arthritis. Ann. Rev. Immunol., 14, 397-440.
7. FIRSTEIN, G.S. & ZVAIFLER, N.J. (1990). How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum., 33, 768-773.
8. GREGORY, S.H., WING, E.J., HOFFMAN, R.A. & SIMONS, R.L. (1993). Reactive nitrogen intermediates suppress the primary immunologic response to listeria. J. Immunol., 150, 2901-2909.
9. IANARO, A., O'DONNEL, C.A., DI ROSA, M. & LIEW, F.Y (1994). A nitric oxide inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances IL-10 production in carrageenin-induced oedema in mice. Immunol., 82, 370-375.
10. KAVANAUGH, A.F. (1998). Anti-tumor necrosis factor-alpha monoclonal antibody therapy for rheumatoid arthritis. Rheum Dis. Clin. North. Am., 24, 593-614.
11. KLIMIUK, P.A., YANG, H., GORONZY, J.J. & WEYAND, C.M. (1999). Production of cytokines and metalloproteinase in rheumatoid synovitis is T cell dependent. Clin. Immunol., 90, 65-78.
12. MCCARTNEY-FRANCIS, N., ALLEN, J.B., MIZEL, D.E., ALBINA, Q. & XIE, Q.-W. (1993). Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med., 178, 749-754.
13. MCINNES, I.B., LEUNG, B.P., FIELD, M., WEI, X.Q., HUANG, F.-P., STURROCK, R.D., KINNINMONTH, A., WEIDNER, J. MUMFORD, R. & LIEW, F.Y. (1996). Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J. Exp. Med., 184, 1519-1524.
14. MONCADA, S. & HIGGS, A. (1993). The L-arginine-nitric oxide pathway. N. Engl. J. Med., 29, 2002-2012.
15. MORELAND, L.W. (1998). Soluble tumour necrosis factor receptor (p75) fusion protein (ENBREL) as a therapy for rheumatoid arthritis. Rheum. Dis. Clin. North. Am., 24, 579-691.
16. PANAYI, G.S., LANCHBURY, J.S. & KINGSLEY, G.H. (1992). The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthr. Rheum., 35, 729-735.
17. PEARSON, C.M. (1963). Experimental joint disease. Observations on adjuvant-induced arthritis. J. Chron. Dis., 16, 863-874.
18. PEARSON, C.M., WAKSMAN, B.H. & SHARP, J.T. (1961). Studies on arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. J. Exp. Med., 113, 485-509.
19. RANDALL, L.O. & SELITTO, J.A. (1957). Method for measurement analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn., 111, 233-249.
20. SENG, G.F., BENENSOHN, J. & BAYER, B.M. (1990). Changes in T and B lymphocyte proliferative responses in adjuvant-arthritic rats: antagonism by indomethacin. Eur. J. Pharmacol., 178, 267-273.
21. STEFANOVIC-RACIC, M., MEYERS, K., MESCHTER, C., COFFEY, J.W., HOFFMAN, R.A. & EVANS, C.H. (1994a). N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthr. Rheum., 37, 1062-1069.
22. STEFANOVIC-RACIC, M., STADLER, J., GEORGESCU, G.I. & EVANS, C. (1994b). Nitric oxide synthesis and its regulation by rabbit synoviocytes. J. Rheumatol., 21, 1892-1898.
23. VAN BOXEL, J.A. & PAGET, S.A. (1975). Predominantly T cell infiltrate in rheumatoid synovial membranes. N. Engl. J. Med. 293, 517-520.
24. VAN DEN BERG, W.B. (1998). Role of T cells in arthritis: lessons from animal models. In T cells in Arthritis. eds. Miossec P, van den Berg W.B. & Firstein GS, pp. 75-92. Basel: Birkhauser Verlag.
25. WALLACE, J.L. & CIRINO, G. (1994). Gastrointestinal-sparing NSAIDs on the horizon? Trends Pharmacol. Sci., 15, 405-406.
26. WALLACE, J.L., CALIGNANO, A. & CIRINO, G. (1997). Potential of new NSAIDs as analgesics. Pain Rev., 4, 230-237.
27. WALTZ, D.T., DIMARTINO, M.J. & MISHER, A. (1971). Adjuvant-induced arthritis in rats. II Drug effects on physiological, biochemical and immunologic parameters. J. Pharmacol. Exp. Ther., 178, 223-231.
28. WEI, X.-Q., CHARLES, I.G., SMITH, A., URE, J., FENG, G.J., HUANG, F.P., XU, D., MULLER, W., MONCADA, S. & LIEW, F.Y. (1995). Altered immune response in mice lacking inducible nitric oxide synthase. Nature, 375, 408-411.